Literature DB >> 1971269

Celiac disease is associated with an extended HLA-DR3 haplotype which includes HLA-DPw1.

M A Hall1, J S Lanchbury, W J Bolsover, K I Welsh, P J Ciclitira.   

Abstract

HLA-DP polymorphism was examined among celiac disease patients and controls. Restriction fragment length polymorphism (RFLP) genotyping showed a significant association of DPw1 in celiac disease (32/80) compared with controls (6/53, p = 0.0002). DPw1 typing by RFLP was verified using DPB1-amplified DNA and an oligonucleotide probe specific for the DPw1-associated DPB1 gene. The RFLP-assigned DPw1 genotype corresponded closely to the binding pattern of the sequence-specific oligonucleotide probe, although discrepancies did occur. The association between celiac disease and DPw1, however, remained. Oligonucleotide probe specificity was confirmed by sequencing DPB1-amplified DNA from four DPw1-genotyped celiacs. DPw1 is only present in celiacs who genotype DR3a-positive. Of DR3a controls 24% are DPw1-positive compared with 5% of non-DR3a controls (p = 0.03), suggesting that an extended DR3a, DPw1 haplotype occurs in the control population. This haplotype forms a large proportion of the DR3a haplotypes predisposing to celiac disease. Alternatively, DPw1 may represent an independent risk factor inherited in linkage with HLA-DR3 and -DQw2. Although predisposition to celiac disease is likely to be mediated by a specific DQ alpha/DQ beta heterodimer, a direct role for the DPw1 antigen cannot be discounted.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971269     DOI: 10.1016/0198-8859(90)90052-q

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

Review 1.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 2.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

3.  Nucleotide sequence of a novel HLA-DRB4B1 allele, DRB1*0409.

Authors:  J S Lanchbury; E E Jaeger; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 4.  Molecular biology and coeliac disease.

Authors:  P D Howdle; G E Blair
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

5.  Complement C4 types in coeliacs and controls.

Authors:  J Cahill; F M Stevens; C F McCarthy
Journal:  Ir J Med Sci       Date:  1991-06       Impact factor: 1.568

6.  HLA association with dermatitis herpetiformis is accounted for by a cis or transassociated DQ heterodimer.

Authors:  M A Hall; J S Lanchbury; W J Bolsover; K I Welsh; P J Ciclitira
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

7.  DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus.

Authors:  N A Bishof; T R Welch; L S Beischel; D Carson; P A Donnelly
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

Review 8.  New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.

Authors:  Aaron W Michels; David A Ostrov
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

9.  TAP1 and TAP2 polymorphism in coeliac disease.

Authors:  S H Powis; W M Rosenberg; M Hall; I Mockridge; S Tonks; A Ivinson; P J Ciclitira; D P Jewell; J S Lanchbury; J I Bell
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.